Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors

Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors

US Patent 9540351 · Granted Jan 10, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fms-like tyrosine kinase inhibitors2022
Ammonium salts of 3-(3,5-dibromo-4-hydroxybenzyliden)-5-indo-1,3-dihydroindol-2-2022
3,5-diaminopyrazole kinase inhibitors2017
Isotopically enriched arylsulfonamide CCR3 antagonists2017
3,5-diaminopyrazole kinase inhibitors2017
3,5-diaminopyrazole kinase inhibitors2016
3,5-diaminopyrazole kinase inhibitors2016
3,5-diaminopyrazole kinase inhibitors2016
3,5-diaminopyrazole kinase inhibitors2016
3,5-diaminopyrazole kinase inhibitors2016
3,5-diaminopyrazole kinase inhibitors2016
2,5-disubstituted arylsulfonamide CCR3 antagonists2015